PROK

SetupConviction 48LongHealthcareScan · Fri, Oct 9, 2026

Falling trendline breakchannel

Prokidney Corp. (PROK) closed at $1.75 (+5.12%) on Oct 9, 2026. It is in the "Setting up" lane with a falling trendline break pattern. Price is above its 50-day and below its 200-day moving average. RSI(14) 53, RS Rating 17, -47.1% from its 52-week high, -21.8% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

PROK$1.75+5.12%

ResistanceSupportVol 14Insider sell

Vol MA14 1.25M

Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9

Trade plan

LongReward : Risk1.00

Entry

1.80

Risk

Stop

1.63

-9.2% to stop

Reward

Target 1

1.96

+9.3% to target

Stretch

Target 2

2.13

+18.6% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

PROKIDNEY CORP.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.prokidney.com ↗

Price1.75

Change+5.12%

Gap+0.90%

Rel volume0.77×

Avg volume1.69M

Avg $ vol2.97M

SMA 201.71

SMA 501.69

SMA 2001.88

Price vs 50+3.37%

Price vs 200-7.35%

MA stackmixed

50/200 cross—

Supertrenddown · 1.89

RSI (14)53

MACD hist-0.00

MACD cross—

Stoch %K / %D65 / 35

ADX (14)15

+DI / −DI24 / 20

RSI divergence—

MACD divergence—

ATR %6.34%

ADR %6.49%

52w high3.30

52w low1.33

From 52w high-47.12%

Above 52w low+31.20%

New 52w highNo

SqueezeOff

Bollinger width22.54%

%B0.60

Donchian pos47.78%

Donchian high1.98

Donchian low1.53

AVWAP (52w high)2.00

vs AVWAP high-12.84%

AVWAP (52w low)1.73

vs AVWAP low+0.95%

OBV trendUp

Chaikin MF (20)0.11

Today vs 20d0.77×

Avg vol (14d)1.25M

Avg vol (20d)1.69M

Avg $ vol (20d)2.97M

Market cap107.39M

RS Rating17 / 99

RS 3m (vs SPY)+4.47%

RS 6m (vs SPY)-25.09%

RS line new highNo

Trend template3/8

Technical rank45.6

1 week+1.45%

1 month-5.16%

3 months+8.39%

6 months-10.51%

1 year-46.47%

YTD-21.75%

P/E-1.56

P/B-0.12

P/S120.25

P/FCF-0.79

EPS-0.2300

Div yield—

ROE7.81%

ROA-27.70%

Debt/Eq—

Current8.36

EV/EBITDA-0.21

Gross margin—

Net margin—

Rev growth1075.00%

EPS growth-12.75%

Price target5.75

Target upside229.51%

Analyst ratingHold

Institutional24.13%

Ent. value32.52M

Revenue150K

Net income-28.42M

Gross profit—

Free cash flow-135.31M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out205.2M

Employees231

ListedTue, Jul 12, 2022

Free float102.88M

Float %72.7%

Short interest20.74M

Days to cover17.7d

Short volume71.9%

Squeeze score85 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.15 vs −$0.13

Last surprise-15.4% miss

Setup gradeC

Conviction48 / 100

Pattern quality68%

Tech rank45.6 / 100

Group rank14 / 100

Status laneSetting up

Setup directionLong

Pattern familyChannel

Resistance1.80

Support1.63

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PROK

All disclosures →

No recent disclosed trades by Congress in PROK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PROK · open-market 6 sells

Insider	Side	Shares	Value	Traded	Filed
Pereira Brian JG Director · Class A Common Stock · 2026-08-20	Sell	222.95K	$317K	2026-08-20	2026-08-20
Pereira Brian JG Director · Class A Common Stock · 2026-08-20	Sell	27.05K	$38K	2026-08-20	2026-08-20
Pereira Brian JG Director · Class A Common Stock · 2026-08-19	Sell	222.95K	$321K	2026-08-19	2026-08-20
Pereira Brian JG Director · Class A Common Stock · 2026-08-19	Sell	27.05K	$39K	2026-08-19	2026-08-20
Pereira Brian JG Director · Class A Common Stock · 2026-08-18	Sell	27.83K	$38K	2026-08-18	2026-08-20
Pereira Brian JG Director · Class A Common Stock · 2026-08-18	Sell	229.34K	$314K	2026-08-18	2026-08-20
DOYLE WILLIAM F Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
Pereira Brian JG Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
Legorreta Pablo G. Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
Jimenez Santos Jose Ignacio Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29

SEC filings

EDGAR filings in PROK · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.